Literature DB >> 10660205

Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.

S Senan1, J van Sörnsen de Koste, M Samson, H Tankink, P Jansen, P J Nowak, A D Krol, P Schmitz, F J Lagerwaard.   

Abstract

BACKGROUND: A protocol for the contouring of target volumes in lung cancer was implemented. Subsequently, a study was performed in order to determine the intra and inter-clinician variations in contoured volumes.
MATERIALS AND METHODS: Six radiation oncologists (RO) contoured the gross tumour volume (GTV) and/or clinical target volume (CTV), and planning target volume (PTV) for three patients with non-small cell lung cancer (NSCLC), on two separate occasions. These were, respectively, a well-circumscribed T1N0M0 lesion, an irregularly shaped T2N0M0 lesion, and a T2N2M0 tumour. Detailed diagnostic radiology reports were provided and contours were entered into a 3D planning system. The target volumes were calculated and beams-eye view (BEV) plots were generated to visualise differences in contouring. A software tool was used to expand the GTV and CTV in three dimensions for an automatically derived PTV.
RESULTS: Significant inter-RO variations in contoured target volumes were observed for all patients, and these were greater than intra-RO differences. The ratio of the largest to smallest contoured volume ranged from 1.6 for the GTV in the T1N0 lesion, to 2.0 for the PTV in the T2N2 lesion. The BEV plots revealed significant inter-RO variations in contouring the mediastinal CTV. The PTV's derived using a 3D margin programme were larger than manually contoured PTV's. These variations did not correlate with the experience of ROs.
CONCLUSIONS: Despite the use of an institutional contouring protocol, significant interclinician variations persist in contouring target volumes in NSCLC. Additional measures to decrease such variations should be incorporated into clinical trials.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10660205     DOI: 10.1016/s0167-8140(99)00143-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  25 in total

1.  Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Authors:  I Fotina; C Lütgendorf-Caucig; M Stock; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-01-27       Impact factor: 3.621

2.  A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.

Authors:  Tanja Schimek-Jasch; Esther G C Troost; Gerta Rücker; Vesna Prokic; Melanie Avlar; Viola Duncker-Rohr; Michael Mix; Christian Doll; Anca-Ligia Grosu; Ursula Nestle
Journal:  Strahlenther Onkol       Date:  2015-02-10       Impact factor: 3.621

3.  Comparison of intensity-modulated radiotherapy planning based on manual and automatically generated contours using deformable image registration in four-dimensional computed tomography of lung cancer patients.

Authors:  Elisabeth Weiss; Krishni Wijesooriya; Viswanathan Ramakrishnan; Paul J Keall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-19       Impact factor: 7.038

Review 4.  Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.

Authors:  S Gwynne; E Spezi; D Sebag-Montefiore; S Mukherjee; E Miles; J Conibear; J Staffurth
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

5.  Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.

Authors:  Kishor Karki; Siddharth Saraiya; Geoffrey D Hugo; Nitai Mukhopadhyay; Nuzhat Jan; Jessica Schuster; Matthew Schutzer; Lester Fahrner; Robert Groves; Kathryn M Olsen; John C Ford; Elisabeth Weiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-06       Impact factor: 7.038

6.  Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.

Authors:  Clifton D Fuller; Jasper Nijkamp; Joop C Duppen; Coen R N Rasch; Charles R Thomas; Samuel J Wang; Paul Okunieff; William E Jones; Daniel Baseman; Shilpen Patel; Carlo G N Demandante; Anna M Harris; Benjamin D Smith; Alan W Katz; Camille McGann; Jennifer L Harper; Daniel T Chang; Stephen Smalley; David T Marshall; Karyn A Goodman; Niko Papanikolaou; Lisa A Kachnic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-18       Impact factor: 7.038

7.  A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen.

Authors:  Emmanuel Rios Velazquez; Hugo J W L Aerts; Yuhua Gu; Dmitry B Goldgof; Dirk De Ruysscher; Andre Dekker; René Korn; Robert J Gillies; Philippe Lambin
Journal:  Radiother Oncol       Date:  2012-11-15       Impact factor: 6.280

8.  Interobserver delineation variation in lung tumour stereotactic body radiotherapy.

Authors:  G F Persson; D E Nygaard; C Hollensen; P Munck af Rosenschöld; L S Mouritsen; A K Due; A K Berthelsen; J Nyman; E Markova; A P Roed; H Roed; S Korreman; L Specht
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

9.  Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study.

Authors:  X Allen Li; An Tai; Douglas W Arthur; Thomas A Buchholz; Shannon Macdonald; Lawrence B Marks; Jean M Moran; Lori J Pierce; Rachel Rabinovitch; Alphonse Taghian; Frank Vicini; Wendy Woodward; Julia R White
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

10.  Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists.

Authors:  Chiang J Tyng; Rubens Chojniak; Paula N V Pinto; Marcelle A Borba; Almir G V Bitencourt; Ricardo C Fogaroli; Douglas G Castro; Paulo E Novaes
Journal:  Radiat Oncol       Date:  2009-08-05       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.